Cytotoxic T lymphocytes (CTL) have been implicated in immunity to Plasmodium falciparum infection and disease. We have previously described the use of peptides to define malaria-specific CTL epitopes. To determine whether these peptide epitopes are processed intracellularly from the whole antigen we have developed recombinant vaccinia viruses (rVV) expressing three malaria antigens: thrombospondin-related adhesive protein (TRAP), Pfs16 and the C-terminal half of liver-stage antigen (LSA)-1. Target cells infected with recombinant viruses were lysed by malaria-specific CTL from semiimmune African donors. We also tested the ability of cells infected with these recombinant vaccinia viruses to re-stimulate malaria-specific CTL in peripheral blood lymphocytes from malaria immune adults. Two other pox virus recombinants, NYVAC, an attenuated vaccinia virus, and ALVAC, a canarypox virus, both expressing malaria antigens were also evaluated for their ability to stimulate malaria-specific CTL. In contrast to peptide, none of these viruses successfully re-stimulated CTL from the peripheral blood lymphocytes of semi-immune donors. The ability of human CTL from naturally exposed individuals to recognize processed antigen supports the relevance of these cells in protective immunity to malaria.
Introduction
Class I-restricted CD8 ϩ cytotoxic T lymphocyte (CTL) Human CTL were originally defined to viral pathogens (13) where the use of the virus in in vitro cultures provides a conveniresponses have been shown to be a critical arm of the protective immune response to intracellular pathogens and in some ent method of re-stimulating specific CTL. However, this option is not available in studies of malaria CTL as it is not possible to rodent models of malaria the presence of CD8 ϩ CTL has been shown to correlate with protection from infection (1) (2) (3) . In Plasculture the liver-stage parasite except in a very low percentage of freshly isolated hepatocytes. Thus, the convincing identimodium falciparum infections of humans the evidence that CTL may play a protective role is indirect. The pattern of sequence fication of CTL against P. falciparum awaited the development of peptide-based re-stimulation strategies (9) which have variation in certain CTL epitopes (4, 5) , the finding of an HLA class I association with resistance to severe malaria (6) and the recently been developed extensively (10). However, it would be beneficial if whole antigen systems could be employed identification of malaria-specific CTL in naturally exposed as well as sporozoite-immunized individuals all suggest that CTL for human CTL analysis for two reasons. Firstly, this would overcome the need to use peptides appropriate for particular may play some protective role (7) (8) (9) (10) (11) (12) .
HLA molecules to detect CTL and allow an overall measurement 143 cells in the presence of 5-bromodeoxyuridine and by their ability to express β-galactosidase. Recombinant viruses of the level of the CTL responses to a malaria antigen to be made, independent of the HLA type of the individual. Secondly, were purified by plaque purification and DNA isolated as described (15) . The presence of the appropriate inserts was this would allow assessment of whether human CTL to P. falciparum are capable of recognizing endogenous processed anticonfirmed by PCR. The circumsporozoite protein (CSP) rVV was a gift from B. Moss (NIH, Bethesda, MD) (21). ALVAC gen as well as peptide epitopes applied externally to the surface of target cells. Clearly, to play a protective role, CTL expressing LSA-1 alone or CSP alone and NYVAC expressing LSA-1 alone or CSP alone were a gift from Virogenetics (Troy, should be able to recognize processed antigen as well as peptides.
NY). The LSA-1 gene insert used in these recombinant viruses was without the central repeat region. To address these issues, we have constructed recombinant vaccinia viruses (rVV) containing three pre-erythrocytic antiProtein analysis gens of malaria, two of which we have found to be major CTL-inducing antigens, liver-stage antigen (LSA)-1 and throm-TK -143 monolayers were infected at high multiplicity of infection (30 p.f.u./cell) with wild-type virus (WR) and each of bospondin-related adhesive protein (TRAP) (10). Additionally we have explored the utility in CTL re-stimulation of canarypox the recombinant viruses for 2 h, cells were rinsed, and the infection allowed to continue in complete medium. Cells were (ALVAC) and attenuated vaccinia virus (NYVAC) recombinants (14) containing LSA-1. We find that CTL from naturally exposed harvested 16 h post-infection and lysates prepared using the method described by Mackett et al. (15) . Both lysates and individuals are capable of lysing target cells infected with these recombinant viruses, but that the ability of these recomculture supernatants were examined by Western blot analysis for the presence of the appropriate recombinant protein. binants to re-stimulate CTL in in vitro culture is less than that of short synthetic peptides.
Polyacrylamide gels varying from 7.5 to 12.5% were blotted on to polyvinylidene difluoride membranes and recombinant proteins detected using enhanced chemiluminescence Methods (Amersham, Buckinghamshire, UK). TRAP constructs were detected using a sheep anti-TRAP polyclonal antisera. LSAViruses, cells and parasites 1 was detected using rabbit antipeptide antisera, a gift from Vaccinia virus (strain WR) was propagated in baby hamster M. R. Hollingdale. Pfs16 was detected using a rabbit antisera kidney (BHK) cells as described (15) (RPMI 1640; Sigma, Poole, UK) supplemented with 100 U/ml was cultured as described (16) and DNA extracted as penicillin, 100 µg/ml streptomycin and 4 mM L-glutamine. described by Robson and Jennings (17) . Peptides Plasmid construction Peptides were synthesized based on F-moc chemistry by an Oligonucleotide primers were designed to enable the comautomated peptide synthesizer (Zinsser Analytic). All peptides plete coding sequences of the genes for Pfs16 and TRAP were confirmed to be Ͼ70% pure by HPLC analysis and and partial sequences of LSA-1 and TRAP to be amplified dissolved in PBS or first with 10-20 µl DMSO and subsequently using the PCR. The primers and the sequences amplified diluted with PBS to bring the concentration of DMSO to Ͻ1%. and the cycling conditions are shown in Table 1 . The target CTL re-stimulation DNA was from the cloned line of P. falciparum, T9/96. PCR products were prepared for blunt end cloning into the SmaI For peptide re-stimulation, 1.5-2ϫ10 7 PBL from malaria site of the plasmid pSC11 (18) as described (19) . Recombinimmune donors were incubated with 20 µM peptide in 100 µl ants were detected by colony hybridization using end-labelled of R10 (R0 with 10% FCS) for 1 h at 37°C in the presence of 5% oligonucleotides internal to the PCR primers. The authenticity CO 2 and humidity. Cells were then diluted to a concentration of and orientation of the inserts were confirmed by restriction about 1-1.5ϫ10 6 /ml in R10 and plated out in 2 ml/well in 24-enzyme analysis and dideoxy-nucleotide sequencing using well tissue culture plates (Falcon). Plates were incubated in modified T7 DNA polymerase (Sequenase; US Biochemicals, a humidified incubator at 37°C in the presence 5% CO 2 . After Les Ulis, France) (20).
72 h, 10 U/ml of human rIL-2 (Cetus, Emeryville, CA) was added to the cultures and cytotoxic assays performed at day Recombinant viruses 8 as described (10). Cells not used were maintained on a weekly dose of 10 U/ml IL-2 until tested for cytotoxicity. For Recombinant plasmids were purified by CsCl density gradient centrifugation. TK -143 cells infected with vaccinia virus (strain CTL re-stimulation with recombinant virus, 20% of PBL from a malaria immune donor were infected with 5-20 p.f.u. of WR) at 0.05 p.f.u./cell were transfected with the appropriate calcium phosphate-precipitated plasmid DNA (15). TKvirus/cell and used as stimulator cells. When paraformaldehyde fixation was used, overnight cultures of virally infected recombinants were isolated by plaque assay on human TK -cells were resuspended in 5 ml of 1.5% w/v paraformaldehyde and incubated at 37°C for 20 min. The cells were washed and 5 ml of 0.2 M glycine added for 20 min at 37°C followed by two washes. Virus-infected stimulator cells were incubated with the rest (80%) of the PBL in 24-well plates at 37°C and 5% CO 2 in a humidified incubator. Recombinant virus cultures were incubated with rIL-2 from 72 h onwards for wild-type vaccinia recombinants but not for ALVAC or NYVAC recombinants according to previous optimization studies.
Target cells and cytotoxicity assays
Target cells were Epstein-Barr virus-transformed autologous or HLA-matched B lymphoblastoid cell lines. Then 1-2ϫ10 6 target cells were radioactively labelled with 100 µCi of 51 Cr infected for 1 h with 5-20 multiplicity of infection (m.o.i.) of either recombinant virus of interest or an irrelevant recombinant virus in a small volume (100 µl) of R10 at 37°C. The gene, the p7.5 promoter and appropriate internal sequences irrelevant vaccinia was used as a control because many of indicated that the required sequences had indeed been the subjects studied were likely vaccinated some 10-30 years inserted into the TK gene of the relevant vaccinia virus. ago. Cells were washed once, diluted in R10 to~1ϫ10 6 cell/ Recombinant proteins synthesized by the recombinant ml and incubated over night at 37°C in 5% CO 2 . Radiolabelling viruses were detected by Western blot analysis. Both of the of virus-infected targets was as for peptide-pulsed targets.
recombinant TRAP constructs were found both in the virus 51 Cr-release cytotoxicity assays were performed as described lysates and in the culture supernatants. This was not an (9) . As usual, lysis assays were performed in duplicate wells unexpected finding as TRAP expressed in recombinant bacuand the mean calculated. A positive result was defined as lovirus behaves in the same way (22). The vvCRAP15 con-15% specific lysis of target cells pulsed with relevant peptide struct gave a product of~70 kDa which is comparable to the or infected with relevant recombinant virus over targets not bacterially expressed product of TRAP1.0 (22) which encodes pulsed with peptide or infected with irrelevant recombinant amino acids 26-498 of TRAP. The full-length construct vvTRAP virus: the percentage lysis presented in the figures represents gave a product of similar size and can be compared to the this difference. Spontaneous 51 Cr release in the absence of product expressed in recombinant baculovirus and this may CTL was always Ͻ25% of maximum release by 5% Triton.
represent processing of the full-length protein in these systems (Fig. 1) .
Results
Pfs16 gave a protein of expected size on Western blots. It was only found in the cell lysate fraction as recently reported Construction of rVV for an independently constructed recombinant virus (23) . The C-terminal portion of LSA-1 that was expressed had been The amplified gene sequences were cloned into the SmaI site of pSC11 which is downstream of the p7.5 promoter predicted to produce a protein of~30 kDa. Both antipeptide sera detected two closely migrating bands of much larger and flanked by TK sequences. The plasmids generated were pSC11TRAP, pSC11Pfs16, pSC11LSA-1/8.5 and mol. wt,~45 kDa. Although this was an unexpected finding, many malarial proteins migrate anomalously in denaturing pSC11CRAP15. Sequencing of the inserts of these plasmids confirmed their authenticity and whether any errors had polyacrylamide gels and this observation for LSA-1 has been confirmed by M. Hollingdale (pers. commun.). It is possible been incorporated during PCR amplification. One error had occurred in the CRAP15 construct, slippage in a block of that the decreased mobility is due to glycosylation. There is one N-linked glycosylation consensus sequence in this part poly(dA) towards the end of the sequence caused a change in reading frame such that the last 12 amino acids after the of the molecule. Alternatively it could be due to some other post-translational modification. LSA-1 protein was found in three in-frame lysines were ENQIINIKLQVE giving a final length of 500 amino acids where 488 corresponded to the the cell lysates and some was also detected in the culture supernatants. authentic T9/96 TRAP sequence. These plasmids were used to co-transfect TK -143 cells with vaccinia virus (WR), TKPeptide-re-stimulated CTL recognize processed antigen recombinants were selected for by plaque assay for β-galactosidase expression in the presence of 5-bromodeoxyWe tested the ability of LSA-Vac-infected target cells to process and present malaria peptides to synthetic peptide uridine. The rVV were vvTRAP, vvPfs16, vvCRAP15 and vvLSA1/8.5. Analysis of the viral DNA by polymerase chain re-stimulated CTL. CTL lines specific for HLA-B53-restricted CTL epitope ls6 (9) recognized LSA-Vac-infected target cells amplification in the presence of primers both to the TK 
CTL re-stimulation with other recombinant viruses though the level of lysis was not as high as for peptide
Recently highly attenuated viruses and viruses with restricted pulsed targets (Fig. 2) . HIV-gag-Vac-infected targets were not growth in certain host cells have been described (28, 29) . Two recognized by these CTL. This result showed that ls6 was such recombinant virus delivery systems are being developed processed endogenously from the Lsa-Vac antigen and was by Virogenetics. One is NYVAC, an attenuated vaccinia virus recognized by ls6-specific CTL. Recently, in studies of malcharacterized by a lack of 18 open reading frames resulting aria-immune Tanzanians we have found that CTL specific for in decreased virulence and altered infectivity of certain host the peptide epitopes tr26, tr29 and tr39 from TRAP recognize cells (30) . The other is ALVAC, a canarypox virus vector which target cells infected with the recombinant virus (24) . To date replicates productively only in avian cells, and has been we have not detected CTL to Pfs16 in any malaria immune shown to process and present foreign gene inserts in mammadonor, so it has not been possible to test for lysis of target lian cells (31) . Both viruses are non-pathogenic in man. cells infected with the rVV virus.
From a malaria-immune adult who responds to a nonamer peptide from the P. falciparum liver-stage antigen LSA-1, ls6, CTL re-stimulation with rVV expressing malaria antigens peptide-re-stimulated CTL from PBL lysed target cells pulsed Two major requirements for the use of recombinant viruswith ls6 in a 4 h Cr-release assay (Fig. 4) . These CTL were infected stimulator cells for in vitro CTL stimulation are that ls6 specific and did not lyse target cells pulsed with irrelevant there should be a way of limiting reproductive replication of control nonamer epitopes from CSP, cp6, or LSA-1, ls23; a the virus so that lysis of the antigen-presenting cell by the peptide that does not bind to HLA-B53 in binding assays virus does not occur and also that there is early and adequate (data not shown). Cells from the same individual taken at the expression of the inserted antigen. The former may be same time but re-stimulated with autologous PBL infected with achieved by UV irradiation of virus-infected cells after a few NYVAC-LSA 1, ALVAC-LSA 1 and LSA-Vac, all recombinant hours growth post-infection in vitro (25) . However, preliminary viruses, showed no lysis of ls6-pulsed target cells (Fig. 3) . studies of this inactivation method failed to yield effective CTL This result showed that although it was possible to re-stimulate re-stimulation. Other methods used are paraformaldehyde ls6-specific CTL with peptide and show lysis of peptidefixing (26) or mitomycin treatment of virus-infected stimulator pulsed targets, lysis of these target cells was not observed cells. Here we have used paraformaldehyde fixation which following re-stimulation with recombinant virus-infected donor has been previously reported to successfully re-stimulate HIV-PBL. It has been suggested (27) that a low m.o.i. leads to a specific CTL (26) .
preferential response of T cells to the foreign gene insert and We failed to demonstrate re-stimulation of malaria-specific not the vector, but for ALVAC-LSA neither m.o.i. of 5 or 20 re-CTL with rVV expressing LSA-1 (Fig. 3) , CSP, Pfs16 and TRAP stimulated detectable CTL as assayed by lysis either of after testing on peptide pulsed targets and rVV-infected peptide-pulsed targets (Fig. 4) or LSA-Vac-infected targets targets (data not shown). In some assays where rVV infected (not shown). targets were used, there was enhanced lysis of wild-type vaccinia-infected targets, targets infected with rVV expressing Discussion P. falciparum antigens and targets expressing HIV-gag. Such non-specific lysis of wild-type vaccinia virus and rVV has
The low precursor frequencies of CTL to P. falciparum in naturally exposed individuals (10 and Plebanski et al., submitbeen reported previously (27) . L d -positive cells using peptides known to be restricted by H-2L d . Also, it has been shown that there is down-regulation of HLA class I molecule expression on the cell surfaces after viral infection (34) (35) (36) . These two phenomena occurring on peptide-pulsed and virus-infected target cells would lead to a marked difference in the levels of class I MHC expressed on the cell surfaces. In situations where down-regulation of virus-infected cells significantly reduces cell surface class I expression, there may be less than optimal peptide presentation resulting in an impaired ability of these cells to re-stimulate CTL. As we have shown here, even when virus-infected targets are lysed by CTL, the level of lysis is lower than lysis of peptide-pulsed targets by the same CTL. It has been suggested that CTL re-stimulation in vitro requires the presence of more peptide-MHC complexes on the cell surface than is required for sensitization of targets for lysis by CTL (33) . Alternatively, we speculate that infection of dendritic cells by vaccinia viruses in vitro may be inefficient. Thus, if The development of the ALVAC and NYVAC recombinant viruses is a promising advance for human vaccine development. However, we failed to show in vitro CTL stimulation of ted) required a good re-stimulation system to allow CTL PBL from individuals naturally exposed to malaria despite detection using standard bulk culture CTL assays. Although encouraging evidence of the immunogenicity of other such peptide-re-stimulation methods based on the peptide-binding recombinants in mice and humans. ALVAC and NYVAC carrymotif for particular HLA types have led to the identification of ing the HIV-1 env gene have been shown (14) to elicit numerous minimal epitopes, large numbers of peptides are protective immunity in naïve mice and this immunity is medirequired to screen a complete antigen for multiple HLA types. ated through both antibody and CTL. A P. berghei NYVACFurthermore, several different P. falciparum antigens are CSP recombinant has been found to produce significant recognized by the CTL of individuals from malaria-endemic protection against this murine malaria species (37) . NYVACareas. We show here that CTL re-stimulation by peptide is Pf7, a rVV expressing seven P. falciparum antigens, is currently more efficient than re-stimulation by wild-type or attenuated in early clinical trials (38) . However, to date information on (NYVAC) rVV-infected cells or cells infected by recombinant the re-stimulatory capacity of these viruses for human CTL is canarypox virus (ALVAC). We were not able to compare these very limited. Our findings suggest that in human trials of CTLre-stimulation protocols with stimulation with transfected cells inducing vaccines, peptide re-stimulation should be a better expressing relevant antigens or proteins. However, studies approach to CTL detection than the use of these recombinof hepatitis CTL comparing PBL loaded with peptide to ants viruses. transfected autologous cells found that HBV-specific CTL We have also shown that the ls6 epitope defined by peptide were consistently detected only by peptide re-stimulation re-stimulation is processed and presented by rVV-infected (32). Van Baalen et al. (26) have reported the detection of HIVtarget cells and that once CTL have been re-stimulated using specific CTL employing re-stimulation with paraformaldehydepeptides, they can recognize this epitope presented on the fixed recombinant vaccinia-infected cells as employed here.
surface of recombinant virus-infected target cells. Recently, However, HIV-specific CTL precursor frequencies are often we have extended this work to show that the rVV with much higher than these observed to malaria epitopes, sug-TRAP can be recognized by peptide re-stimulated CTL from gesting that, in the presence of a higher precursor frequency Tanzanian blood donors (24) . Although recognition of malaria of CTL, such a method may be effective.
antigens expressed by rVV does not prove that these parasite However, our data strongly suggest that short peptides are epitopes will be recognizable at the surface of infected more efficient re-stimulators of malaria CTL than recombinant hepatocytes, it does indicate that processing and recognition viruses. The explanation for this difference is uncertain. Howof these epitopes in human target cells is possible. Further ever, peptides can up-regulate the expression of class I technical developments should allow assessment of whether molecules on some cells. Alexander and co-workers (33) reported a 2-to 4-fold increase in the level of L d on cultured human CTL can lyse parasite infected hepatocytes as has 
